Managers / Q2 2020 · view latest →
HARBOURVEST PARTNERS LLC
CIK 0001201001 · ONE LINCOLN STREET, SUITE 1700, BOSTON, MA, 02111 · 617-348-3707
Summary
Harbourvest Partners LLC reported $232M in U.S.-listed holdings across 28 positions for Q2 2020.
The portfolio is heavily concentrated: Solarwinds alone accounts for 60.0% of reported value.
Compared with Q1 2020, the fund opened 3 new positions and exited 11.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.5% · $198M
- Other · 13.7% · $32M
- ADR · 0.7% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TENBTenable Holdings, Inc. | NEW | +55.4K | 55.4K | +$2M | $2M |
| IVERIC Bio, Inc. | NEW | +308.5K | 308.5K | +$2M | $2M |
| Epizyme, Inc. | NEW | +24.7K | 24.7K | +$396,000 | $396,000 |
| Axcella Health, Inc. | ADDED | +1.58M | 2.81M | +$11M | $16M |
| FSLYFastly, Inc. | SOLD OUT | −229.8K | 0 | −$4M | $0 |
| U.S. Auto Parts Network, Inc. | SOLD OUT | −1.48M | 0 | −$3M | $0 |
| ALRMAlarm.com Holdings, Inc. | SOLD OUT | −52.8K | 0 | −$2M | $0 |
| PDPagerDuty, Inc. | SOLD OUT | −54.2K | 0 | −$937,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | Solarwinds Corp. | Common | 59.96% | $139M | 7.87M |
| 2 | Axcella Health, Inc. | Common | 6.69% | $16M | 2.81M |
| 3 | Evelo Biosciences, Inc. | Common | 6.47% | $15M | 3.06M |
| 4 | KLDOKaliedo Biosciences, Inc.history → | Common | 5.87% | $14M | 1.83M |
| 5 | WORKSlack Technologies, Inc.history → | Common CL A | 3.82% | $9M | 285.3K |
| 6 | Finjan Holdings, Inc. | Common | 2.86% | $7M | 4.30M |
| 7 | Rubius Therapeutics, Inc. | Common | 2.54% | $6M | 986.9K |
| 8 | PINSPinterest, Inc.history → | Common CL A | 2.02% | $5M | 211.3K |
| 9 | SONOSonos, Inc.history → | Common | 1.91% | $4M | 303.3K |
| 10 | Zuora, Inc. | Common | 1.03% | $2M | 187.4K |
| 11 | LendingClub Corp. | Common | 1.01% | $2M | 513.4K |
| 12 | YEXTYext, Inc. | Common | 0.82% | $2M | 115.1K |
| 13 | SFIXStitchfix, Inc. | Common CL A | 0.72% | $2M | 66.6K |
| 14 | Spark Networks SE | Sponsored ADR | 0.72% | $2M | 502.6K |
| 15 | TENBTenable Holdings, Inc. | Common | 0.71% | $2M | 55.4K |
| 16 | IVERIC Bio, Inc. | Common | 0.68% | $2M | 308.5K |
| 17 | PluralSight, Inc. | Common CL A | 0.41% | $958,000 | 53.1K |
| 18 | LYFTLyft, Inc. | Common CL A | 0.37% | $851,000 | 25.8K |
| 19 | CTMXCytomx Therapeutics, Inc. | Common | 0.28% | $660,000 | 79.2K |
| 20 | Proteostasis Therapeutics, Inc. | Common | 0.26% | $604,000 | 440.6K |
| 21 | Epizyme, Inc. | Common | 0.17% | $396,000 | 24.7K |
| 22 | Trevena, Inc. | Common | 0.15% | $351,000 | 233.8K |
| 23 | ARAntero Resources LLC | Common | 0.14% | $335,000 | 131.9K |
| 24 | XGNExagen, Inc. | Common | 0.14% | $322,000 | 26.0K |
| 25 | Castlight Health, Inc. | Common CLB | 0.12% | $290,000 | 349.1K |
| 26 | NextCure, Inc. | Common | 0.09% | $215,000 | 10.0K |
| 27 | Ramaco Resources, Inc. | Common | 0.01% | $32,000 | 15.0K |
| 28 | HNRGHallador Energy Resources, Inc. | Common | 0.00% | $9,000 | 14.3K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $101M | 5 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $174M | 7 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $205M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $91M | 15 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $154M | 16 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $203M | 22 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $192M | 34 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $188M | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $219M | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $299M | 53 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $295M | 58 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $352M | 60 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $297M | 63 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $299M | 65 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $306M | 67 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $305M | 62 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $490M | 66 | May 26, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2021 | $782M | 67 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 56 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.0B | 51 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $746M | 44 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $256M | 26 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $270M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 28 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $207M | 36 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $243M | 35 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $240M | 33 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $262M | 32 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $283M | 33 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $211M | 32 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.